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9.1 Abstract  
Calcium phosphates are the mineral component of bones and teeth. As such there is great 
interest in understanding the physical mechanisms that underlie their growth, dissolution, 
and phase stability. Control is often achieved at the cellular level by the manipulation of 
solution states and the use of crystal growth modulators such as peptides or other organic 
molecules. This chapter begins with a discussion of solution speciation in body fluids and 
relates this to important crystal growth parameters such as the supersaturation, pH, ionic 
strength and the ratio of calcium to phosphate activities.  We then discuss the use of 
scanning probe microscopy as a tool to measure surface kinetics of mineral surfaces 
evolving in simplified solutions. The two primary themes that we will touch on are the 
use of microenvironments that temporally evolve the solution state to control growth and 
dissolution; and the use of various growth modifiers that interact with the solution species 
or with mineral surfaces to shift growth away from the lowest energy facetted forms. The 
study of synthetic minerals in simplified solution lays the foundation for understand 
mineralization process in more complex environments found in the body. 
9.2 Introduction  
 
Organisms use complex, biologically regulated processes with many feedback loops to 
create microenvironments that induce nucleation and growth. This is often achieved at 
the cellular level by generating organic templates and solution states that in turn control 
crystallization. Similarly dissolution processes, such as found in healthy bone 
remodeling, or as found in diseases such as caries and osteoporosis, reflect an underlying 
chemistry that has been biologically manipulated to favor resorption. In general, 
solutions, proteins, and templates act together to control growth and dissolution. In this 
chapter we focus on the role of the solution as a model environment for modifying 
growth kinetics and thermodynamics of calcium phosphate minerals. 
 
Model solutions represent aspects of body fluids such as serum, urine, or saliva, but do 
not contain the full complement of ions and proteins found in biological systems. There 
are many virtues of model solutions, chief among them reproducibility and the ability to 
explore systematic variations about a norm. The use of simplified environments is not 
meant to mimic biosystems so much as to address how plausible changes in the solution 
chemistry impact mineralization This simplification has the advantage of allowing one to 
ask specific questions such as: How does citrate impact brushite crystallization? – A 
query that complements biological or medical motivated questions such as: Does citrate 
act as a therapeutic for kidney stone formation? The study of synthetic minerals in 
simplified solution lays the foundation for understand mineralization process in more 
complex environments found in the body.  
 
This chapter begins with a discussion of solution speciation in body fluids and relates this 
to important crystal growth parameters such as the supersaturation, pH, ionic strength and 
the ratio of calcium to phosphate activities. We then discuss how scanning probe 
microscopy can be used to investigate surface kinetics of mineral substrates evolving in 
simplified solutions. The goal of this style of experiment is to develop an understanding 
of the mechanisms by which growth modifiers alter crystal growth. 
9.3 Calcium phosphate phases found in biology 
 
Organisms have adopted various strategies for creating hard tissues suitable for bearing 
loads. Marine organisms such as mollusks and algae have adapted to take advantage of 
materials in their external environment by creating exoskeletons and grinding appendages 
composed of calcium carbonates or silica. For example the layered nacre of the abalone 
shell is composed of alternating sheets of crystalline calcite and aragonite intertwined 
with organic binders; the intricate frustule of the diatom is a glass composed of very pure 
silica; and the grinding teeth of the sea urchin are composed of calcite but hardened with 
“impurities” of magnesium[1].  These examples serve as archetypes of the complex 
structures found in nature due to the bioavailability of carbonates and silicates in oceans 
(and lakes). By contrast, the interiors of organisms are bathed in phosphate, part of our 
adenosine triphosphate (ATP) driven energy cycle.  As a result, our body fluids are 
consistently supersaturated with respect to calcium phosphates and our endoskeletons and 
other load bearing mineralized tissue like teeth have evolved to reflect this chemistry. 
 
Whether carbonate, silicate, or phosphate, biominerals adopt interesting strategies to 
expand the versatility of the relatively simple base materials. In the examples above, the 
abalone shell gains strength and limits crack propagation because it is an organic-
inorganic composite composed of two polymorphs; the diatom makes use of amorphous 
instead of crystalline materials; and the sea urchin uses impurities to confer changes in 
mechanical properties. These strategies can also be found paralleled in calcium phosphate 
structures. For example, bones tune elasticity and hardness with a collagen-mineral 
composite[2]; matrix vesicles, which mineralize bone, are thought to store stabilized 
amorphous calcium phosphate[3]; and teeth are less soluble when small concentrations of 
fluorine incorporate into their outer layers[4]. There have been several books and reviews 
beyond the current volume that discuss the general assembly strategies that lead to 
complex biomaterials[5-8] and it is not our purpose to review them here. The two 
primary themes that we will touch on are the use of microenvironments that temporally 
evolve the solution state to control growth and dissolution; and the use of various growth 
modifiers that interact with the solution species or with mineral surfaces to shift growth 
away from the lowest energy facetted forms that are defined by the crystal Wulff plots. 
 
The calcium phosphate phases of interest in biology include amorphous calcium 
phosphate, as well as several crystalline forms with names, abbreviations and some 
physical properties summarized in Table 9.1. These materials have been thoroughly 
reviewed by several authors[9, 10]. Typically, biogenic calcium phosphate is not pure, 
but rather substituted, as shown for the apatites: bone, enamel, and dentine. 
 
For the most part healthy mineralized tissues are hierarchical composites composed 
principally of magnesium and carbonate substituted hydroxyapatite closely associated 
with a collagen matrix. Dentin and cementum in the tooth, and the various forms of 
bone[12]  are all approximately 70 wt.% apatite with 20% collagenous matrix and 10% 
water. Enamel, which unlike the other tissues, contains no cells or pores is almost 95 wt. 
% mineral[9]. Enamel also differs in that it is associated with proteins enamelin and 
ameliogenin rather than collagen.  While these biomaterials have broad similarities, they 
differ in important details including their minor elements, water composition, and degree 
of crystallinity[9]. 
 
Table 9.1 provides solubility products for synthetic and biogenic calcium phosphate 
phases. As noted in the table, the biogenic apatite, enamel, dentine, and bone, are impure 
and non-stoichiometric. Major impurities (in weight percent) include carbonate (3.5-
7.4%), which has been shown to substitute for phosphate, as well as sodium (0.5-1%), 
magnesium (0.4-1.2%), potassium (0.03-0.08%), chloride (0.01-0.3%) and fluoride (0.01-
0.06%)[13, 14]. The impurities typically shift the solubility making biogenic apatite 
considerably more soluble than synthetic HAP. Despite the impurities, one needs only to 
look at a skeleton to know that bones and teeth are sparingly soluble. And yet, although 
skeletons can last thousands of years in the environment, within the body, bones are 
constantly being dissolved from one location and deposited in another as a response to 
mechanical stress and hormonal environment. On average, bones are dissolved and 
rebuilt every 30 years (based on 3% per year rate for cortical bone in healthy adults). To 
accomplish this, the body uses specialized cells and vesicles, to create 
microenvironments that regulate Ca2+, HPO42-, and H+ to favor crystal growth or 
dissolution.  
 
Apatite is the dominant calcium phosphate phase found in mineralized tissue; however, 
other transitory phases are postulated in healthy mineralization and are found stabilized 
for longer duration in pathological mineralization. A few examples, by no means 
exhaustive, are indicated in Table 9.2. Model solutions that may serve as a starting point 
for investigating the mineralization dynamics are also indicated.  
 
9.4 Solution chemistry in the body 
9.4.1 Solution speciation 
Solution speciation is the starting point for quantitative solution crystal growth. To model 
the thermodynamic properties of a solution it is first necessary to know the solubility 
product (Ksp) and the association constants (Ka) for all possible solid and solution species. 
Due to the many solid calcium phosphate phases (Table 9.1) and solution complexes (not 
shown), calcium phosphate chemistry is extremely complicated even in simplified, model 
environments. And despite the maturity of this field the databases continue to evolve as 
new methods improve the accuracy of solubility measurements [20].   
 
Solution speciation techniques, which have been made routine with commercial and 
shareware programs, calculate the concentrations and activities of all solution ions and 
complexes from a list of initial reactants and a database of potential reactions with their 
respective association constants and solubility constants[26]. Typically a solution is 
described in terms of ion or salt concentrations (such as in Table 9.3) however it is the 
activities that determine the full speciation. Speciation shown in this chapter uses 
GeoChemists’ WorkBench[27] with an extended Debye-Huckle formulae[28] to define 
the activity coefficients.  
 
9.4.2 Crystal growth parameters 
Once speciation has been accomplished, the activities can be recast in terms of 
parameters that affect crystallization (lower half of Table 9.3). In general these 
parameters can affect both the solution speciation (which is a thermodynamic 
consideration) as well as the surface of the mineral (which can be either a thermodynamic 
consideration such as shifting the hydrated state of the surface with pH, or a kinetic 
consideration affecting the activation barriers associated with incorporation). This section 
will briefly discuss the roles of supersaturation, pH, ionic strength and ratio of cations to 
anions. The effects of each of these parameters are summarized in Table 9.4. The effects 
of additives will be covered in section 9.6.  
The most important crystallization parameter is the thermodynamic driving force or the 
supersaturation. The supersaturation, 
! 
" = #µ /kT , is a unitless number proportional to the 
chemical potential difference associated with molecules transferring from the bulk 
solution to the bulk solid phase and can be determined from speciation calculations. 
Three related representations for the driving force are found in the literature: the 
supersaturation, the supersaturation ratio, and the relative supersaturation. It is 
instructive to spend a moment to define the relationship between these terms.  
 
The supersaturation ratio can be computed from the solution speciation results by 
disallowing precipitation so that all ions remain in the solution phase. From this one can 
calculate the ion activity products (IP) for minerals of interest. The supersaturation ratio, 
S is then given by 
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where the supersaturation ratio for hydroxyapatite (half unit cell) and brushite are shown 
explicitly. For S=1, the mineral and solution are in equilibrium, for S<1 the solution is 
undersaturated and the mineral will dissolve, and for S>1 the solution is supersaturated 
and the mineral will grow. Usually the half unit cell notation is used for octacalcium 
phosphate and the various apatites. In this representation Ksp,HAP = 10-58.65 (as shown in 
Table 9.1) and 9 growth units are denoted in the activity product. In the full unit cell 
representation 18 growth units appear in the activity product and the solubility product is 
correspondingly squared, Ksp,HAP,full = 10-117.3. From this example one can see that 
! 
SHAP, full = SHAP,half
2 , which highlights the necessity of normalizing by the number of growth 
units (n) when making comparisons between minerals with different numbers of growth 
units. Traditionally the supersaturation is written per molecule rather than per growth unit 
and is related to S through 
! 
" = #µ /kT = lnS . To allow comparisons between phosphate 
phases, it is useful to define a driving force that is normalized for the number of growth 
units in the unit cell (n),  
! 
" gu=
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1
n          (9.2) 
where ‘gu’ denotes growth unit. Notice that for S~1 (i.e. near saturation) the logarithm 
can be expanded (lnx~1-x for x~1) leading to what is commonly termed, the relative 
supersaturation, defined as: 
! 
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= S
1/ n
#1,          (9.3) 
In this chapter we will use equation 9.2 because of the broad range of supersaturation 
ratios found in body fluids.  
 
In equilibrium σgu=σrel=0 however most solutions have a metastable region region, where 
the σ>0 and yet the supersaturation is not high enough for crystals to spontaneously 
precipitate from solution phase. Above a supersaturation threshold the These regimes are 
schematically represented in Figure 9.1 plotted against the calcium to phosphate activity 
ratio to highlight the fact that a solution with a fixed supersaturation can be either 
phosphate rich (left side of the graph) or calcium rich (right side of the graph). 
Thermodynamically these solutions will have the same driving force for growth but the 
kinetics can differ substantially.  
 
The second parameter, pH affects both the solution as well as the mineral surface.  In the 
solution, a shift to lower pH will lower the saturation state by shifting the balance of 
phosphate species from PO43- to HPO42- to H2PO4-. At the mineral surface the pH can 
shift the surface charge by changing the distribution of proton and hydroxyl groups 
hydrating the interface.  For hydroxyapatite the point of zero charge (in solutions without 
calcium) occurs at pH=7.3. For more alkaline solutions the surface is negatively charged 
whereas for more acidic, it is positively charged. However, ions other than H+ and OH- 
can adjust surface charge and in calcium containing solutions, the Ca2+ ions bind to the 
surface for pH >7, leaving the surface neutral rather than negative (provided calcium 
remains in solution)[29]. 
 
The third parameter, ionic strength plays a role in screening both ion-ion electrostatic 
interactions in solution (which is accounted for by the activity coefficient) and 
electrostatic interactions between ions in solution and the surface. The ionic strength of a 
solution, I, is defined as  
! 
I = 1/2 [i]zi
2
i
" , 
where [i] is the concentration and the zi the charge, of each ionic species, i. The Debye 
length sets the screening range at the mineral surface and thus sets a length scale for the 
electric field generated at the charged surface. In most biological systems the ionic 
strength is near 0.15M corresponding to a Debye length of approximately 1nm.   
 
Temperature is generally an important crystal growth parameter although it is not a 
variable in a regulated environment such as the body. Many solubility products and 
association constant are temperature dependent thus so is the solution speciation.  
Temperature also effects the kinetics of adsorption, desorption, and diffusion. Within 
transition state theory, these motions are typically modeled as activated hopping 
processes where the probability of making the jump can be written as 
! 
P = " (T )e#Ea / kT . The 
attempt frequency, υ, is weakly temperature dependent and is typically treated as 
independent of temperature. Thus, the primary temperature dependence is the exponent. 
However, in biological systems temperature is regulated and remains nearly constant 
(37ºC for humans) thus while temperature can be used as a tool in vitro to measure 
activation barriers (Ea), it is not a control used in vivo. 
 
Parameters such as the ratio of calcium and phosphate activities acknowledge that growth 
rates may not be dictated simply by the supersaturation and the surface energies but 
rather that kinetics may play a role. In principle ion ratios can affect growth rates, growth 
shape, and the transformation of meta-stable phases. The growth of a multi-species  
crystal relies on the relative rates of adsorption and desorption of the various ions or 
growth units that make up the unit cell. For a simple salt such as NaCl the growth units 
are the Na+ and Cl- ions. However in general the growth units represent the pathway with 
the lowest activation barrier that allows an ion to move from the solution state to the solid 
state and vice-versa. In a binary ionic compound such as brushite, it is tempting to think 
of the growth units as Ca2+ and HPO42-, but it is possible that in the process of shedding 
waters of hydration and incorporating into the solid that the activation barrier is lower for 
a multi-step process wherein one of the other phosphate complexes adsorbs and then adds 
or sheds a hydrogen. The graphs shown in this chapter use the ratio of the calcium ion 
activity to the total phosphate ion activity ({Pi}={H2PO4-} + {HPO42-} + {PO43-}) to 
accommodate the uncertainty in rate-limiting ions. Many groups have shown that ion 
ratios play a role in kinetics and some progress has been made at modeling these 
effects[30]; however, most crystal growth models assume a single species and more work 
is needed to fully describe multi-component crystals. 
  
9.4.3 The speciation of body fluids 
The compositions and resultant crystal growth parameters for common body fluids 
including serum, saliva, enamel fluid, plaque, and urine are summarized in Table 9.3.  
Note that the calcium, phosphate and pH values have broad ranges reflecting temporal 
and population variability. Saliva, plaque fluid and urine are especially affected by 
external factors such as diet and this is reflected in their wide range of values. The 
exceptions are the pH of serum, which is regulated, and enamel fluids where little 
information is available. Table 9.3 also lists the range of values of the important crystal 
growth parameters as are determined by speciating the average solution chemistries over 
all combinations of maximum and minimum calcium and phosphate concentrations and 
pH. 
 
One way of summarizing the variability of parameters in these solutions is to construct a 
map. The solutions maps in Figure 9.2 express the supersaturation (per growth unit) as a 
function of the calcium to phosphate activity and the pH for HAP (low solubility) and 
DCPD (high solubility). These are shown for the body fluids listed in Table 9.3. The 
bounding areas of Figure 9.2a were determined by speciating all combinations of the 
maximum and minimum calcium and phosphate concentrations and pH values in the 
presence of the average concentrations of the other ions listed. The curves in Figure 9.2b 
were generated by speciating the average concentrations of all listed ions over the entire 
normal pH range. Note that HAP and DCPD were chosen to display as bounding cases 
and that the minerals with intermediate solubilities will fall between these plotted range 
of values. 
 
From these maps we can make several observations. First, most body fluids are richer in 
phosphate than calcium with serum being the exception. In serum the Ca/PO4 ratio is near 
that found in bone (1.66) and likely plays a role in creating crystals with this 
stoichiometry during the body’s cycle of bone reformation. Secondly, HAP is 
supersaturated in all fluids over almost their entire range, with the result that under most 
conditions our bones and teeth are stable. And in fact, solution conditions need to be 
explicitly modified to dissolve biological apatites as will been seen in the example of the 
osteoclast. DCPD, on the other hand, lies nearer to the saturation border and is both 
under- and super-saturated. In healthy conditions, as represented by these solutions, HAP 
is always more supersaturated than DCPD; however at lower pH values one can see that 
the HAP and DCPD stability lines will cross due to the shifts in relative concentrations of 
PO43- and HPO42-. It is thus possible under pathological conditions for DCPD to be more 
stable than HAP, although this requires both higher acidity and higher calcium and 
phosphate concentrations than is normal. Table 9.2 suggests some instances where DCPD 
forms; however it is not clear whether these are cases where DCPD is thermodynamically 
stable or a transitory phase. 
 
Another interesting point is that crystals do not normally nucleate in fluids such as serum 
despite the fact that they are highly supersaturated; this can be attributed in part to the 
metastable region where the probability of homogeneous nucleation is small, and in part 
to the presence of nucleation inhibitors (such as proteins) that are not accounted for in a 
thermodynamic map. In some ways the solution maps of normal, easily accessible body 
fluids give the regions over which nothing much happens – apatites neither dissolve, nor 
do they nucleate. One of the more difficult aspects of biomineralization is determining 
the composition and time-evolution of specialized local environments where crystals are 
forming or resorbing. Several possible pathways have been postulated that illustrate how 
the solution conditions might be manipulated to favor nucleation and dissolution; some of 
these are shown in Table 9.5. The remainder of this section will describe, as an example, 
the possible mechanisms at play when bone minerals are formed and resorbed. 
 
It is currently thought that the growth of individual crystals for bone mineralization takes 
place in two stages - nucleation and subsequent growth- and that these processes occur in 
different solution environments[31, 32]. The nucleation phase occurs in the regulated 
environment of small (~100nm), fluid-filled, phospholipid “containers” called matrix 
vesicles (MV) that are released by osteoblast cells into the surrounding tissue termed the 
osteoid. In general, more favorable nucleation environments can be created by increasing 
calcium or phosphate concentrations, creating suitable templates that reduce interfacial 
energy, or reducing inhibitor concentrations; within the interior of the MVs one (or 
several) of processes must occur. Amongst several potential pathways for initiating 
nucleation[32-34], two of them involve the enzyme alkaline phosphatase. Alkaline 
phosphatase (ALP) is produced by osteoblasts and can react with phosphorylated proteins 
to produce free phosphate.  In principle this would be a mechanism that could be used to 
regulate phosphate concentration[35]. On the schematic solution map (Figure 9.1), the 
initiation of nucleation implies increasing the supersaturation above the metastable line 
into the labile region. Alternatively, or in parallel, ALP hydrolyzes pyrophosphates, 
which are known mineralization inhibitors thus lowering the barrier to nucleation.  Inside 
the MV, the first phase to form is amorphous calcium phosphate, which then transforms 
into apatite with a needle-like morphology. At some point the MV membrane is disrupted 
and the apatite needles finish their growth in the surrounding serum-like solution. This 
example highlights one route for separating nucleation from growth when the two 
processes have different solution requirements. 
 
Controlled dissolution also occurs in an occluded environment as seen under an 
osteoclast cell during mineral resorption. Osteoclasts actively dissolve bone through a 
complex set of linked processes that ultimately produce high concentrations of HCl in an 
occluded region abutting the bone. To generate these high local concentrations of acid, 
the cell seals off a region known as the resorption lacuna and uses a vacuolar-like proton 
pump (H+-ATPase) to transport H+ against a gradient. Chloride channels maintain charge 
balance[36-38]. Within the resorption lacuna, the pH drops to 4.5[39]. Figure 9.3 depicts 
the change in saturation state associated with reducing the pH of a serum-like solution. 
The band spans a range of solubilities from the least soluble synthetic FAP to the most 
soluble dentine; the actual solubility will depend upon the bone composition. A more full 
simulation of this process would also need to account for other changes in the solution 
such as contributions from the dissolving mineral. However from this simple titration one 
can see that that the solution moves from being supersaturated with respect to apatite to 
being undersaturated, thus favoring dissolution.  Similar pH-mediation is found in caries 
where bacterial colonies on the teeth produce lactic and acetic acid as part of their 
metabolic cycle.  
 
9.4.4 Limitations of speciation modeling 
There are a number of limitations to keep in mind particularly with respect to modeling 
mineralization within the body. First, this is a thermodynamic approach and if reactions 
are slow the solution may not reflect its thermodynamic values.  Similarly, mineralization 
inhibitors typically slow kinetics and are not accounted for in a thermodynamic model. 
Also, inherent to any speciation modeling, the calculations reflect the quality and 
completeness of the databases that contain the solubility products and the association 
constants. Speciation becomes more difficult as one includes proteins and organic 
surfaces because the association constants are rarely known for these materials. Similarly, 
we have imperfect knowledge of the local solution environments where mineralization 
occurs. Typical compositions and ranges of bodily fluids such as blood serum and urine 
are accessible and well documented, however the time evolution of the solution 
composition in an occluded environment such as within a matrix vesicle or underneath an 
osteoclast is less well known. Nevertheless, quantitative crystal growth relies on 
speciation and a great number of biomineralization studies could be more easily 
compared and made more rigorous by its application. 
 
9.5  Measuring Crystal growth 
There are a limited number of in situ techniques that are viable in a fluid environment and 
that quantify crystallization dynamics. These include optical spectroscopies such as 
Raman and Fourier-transform infrared spectroscopy; diffraction techniques, such as x-ray 
or neutron (although these typically require a dedicated facility), interferometry, and 
imaging techniques such as video microscopy and scanning probe or atomic force 
microscopy (SPM, AFM). In addition a number of solution probes have been developed 
to monitor aspects of solution chemistry, such as pH probes and ion selective electrodes. 
Most kinetic measurements have been obtained on bulk powders that reflect a distribution 
of facets and surface morphologies.  
 
Bulk crystallization experiments can either be classified either as free drift where the 
solution composition varies due to nucleation and growth, or constant composition 
(CC)[40, 41] where changes in the solution composition are monitored and compensated 
as the crystallization process occurs. In a seeded CC experiment, crystals (with known 
surface area) are placed in a temperature controlled growth chamber with an automated 
titration system to maintain a constant pH or other ion selective electrode reading. As the 
crystals grow, consuming calcium and phosphate from solution, the pH (or {Ca2+}) shifts. 
Based on these changes (and knowledge of the seed materials), calcium and phosphate 
ions are automatically added to the solution to balance the material grown. The crystal 
growth rate is obtained from the additions after normalizing by the crystal surface area; 
noting that the crystal surface area changes throughout the experiment and thus must be 
calculated or measured. Variations on the seeded CC method allow the measurement of 
dissolution rates, nucleation rates, and growth rates for multiple species.  
 
Constant composition experiments have clear advantages for quantitative crystal growth. 
They allow growth rates to be measured systematically as a function of the parameters 
delineated in Section 9.4.2; they test and develop the speciation database; and they 
determine which additives act as inhibitors. Although CC has arguably done more than 
any other single method to develop the quantitative physical chemistry of calcium 
phosphates, it is a bulk method with a limited ability to deduce how and where molecular 
changes occur. The SPM has emerged as a complementary technique that, like CC, 
quantifies kinetics in a fluid environment but measures the crystal surface rather than the 
solution state.  
 
Scanning probe microscopy measures surface morphology by rastering a cantilever over 
the surface and detecting its deflection. The lateral resolution is limited by the probe used 
to scan the surface and is typically 10nm; thus the individual growth units (such as Ca2+, 
HPO42- or PO43-) of a growing crystal are not resolvable except when the crystal is 
composed of large building blocks such as proteins[42]. What makes the SPM valuable 
for crystal growth is its sub-angstrom z-resolution, making it capable of measuring 
atomic steps. For in situ work, temperature and pH-controlled solutions are pumped 
through a fluid cell (Figure 9.4) while the crystal is being imaged. The flow rate is 
adjusted until the surface dynamics are independent of flow ensuring that the system is 
not mass-transport limited. This also ensures that the crystal is responding to a solution 
with the same (constant) composition as the reservoir. Figure 9.5 shows a typical AFM 
image of atomic steps emanating from a dislocation source. In this case the surface is the 
[010] face of a DCPD crystal and the 0.38 nm steps are readily imaged even when 
scanning relatively fast (~12 seconds per image). Sequential images make a movie that 
captures the trajectory of the growing crystal steps allowing direct measurement of the 
step velocities in the different crystallographic directions. Similarly, when the solution is 
undersaturated, etch pits form (Figure 9.6) and their dissolution can be monitored. Both 
growth hillocks and etch pits reflect the underlying symmetry of the crystal (Figure 9.5c) 
which, for the case of DCPD has three steps forming a triangle. 
 
The ability to monitor step dynamics also enables several other fundamental 
measurements beyond step velocity and morphology. The reader is referred to several 
reviews[43, 44] and books[45] that cover these topics. In brief, one important parameter 
that can be measured is the length needed for a step to propagate. When the step is in 
equilibrium this length is termed the critical length and reflects a balance between the 
reduction of energy associated with the chemical potential difference between solution 
and solid, and the increase in energy associated with creating a step-edge. In this case, 
! 
L
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"# /$µ  where γ is the step-edge free energy; from this relation, the step free energy can 
be obtained by measuring the critical length as a function of supersaturation[46]. If the 
step is not in equilibrium, but rather has a low probability of moving due to kinetics, then 
the step length is instead related to the probability of nucleating a kink[47]. There is 
growing evidence that this is a common case for sparingly soluble materials such as 
calcium phosphates[48]. However, the theoretical description of this case is still under 
development. 
 
In the next section we will discuss how SPM can be used to augment bulk rate 
measurements by helping to pinpoint the mechanisms by which impurities or additives 
interaction with the growing crystal surface. 
9.6 Impurity Interactions 
Thus far we have discussed the speciation and growth parameters associated with base 
solutions without inhibitors or growth modifiers such as proteins.  Calcium phosphates 
growth and stability is influenced by a great many inorganic and organic species. Some 
of the major modifiers are a) the ions that are found incorporated into biogenic apatites 
(such as Mg, Cl, Na, CO3, K, F), b) proteins (such as collagen, ameliogenin, albumin), c) 
molecules with phosphate moieties (such as pyrophosphate), and d) molecules with 
carboxyl moieties (such as carbonate, citrate).  
 
There are several generic ways in which an adsorbate can affect growth: it can substitute 
for similar ions within the crystal which may induce strain[49]; it can bind to the surface 
hindering or pinning step motion; and it can adsorb to steps such that the composite has 
new equilibrium facet directions (i.e. by acting like a surfactant)[50]. In addition, some 
adsorbates may act as local ion sources, thereby effectively increasing the local 
supersaturation; this is particularly true for proteins, many of which are known to have a 
high capacity for binding calcium and phosphate. It also possible for adsorbates to block 
or reduce the efficacy of step sources; this has the effect of reducing the step density and 
thereby the facet growth rate. In general when impurities are added to the system, the step 
velocities will change in characteristically different ways (some of which are shown in 
Figure 9.7) and different mechanisms can be distinguished by measuring the step velocity 
as a function of adsorbate concentration and mineral supersaturation. In addition to 
kinetics, AFM images also provide detailed information about which steps are affected 
by the adsorbate and whether new facets or step morphologies are formed.  
 
We will close with two examples that illustrate different mechanisms of inhibiting crystal 
growth. The first example looks at a classic step pinning process as peptides interact with 
a calcium carbonate (calcite) crystal first slowing and finally stopping step propagation. 
The second example examines the interaction of citrate with DCPD and shows that step 
kinetics are unaltered but that step density is reduced. In both cases bulk measurements of 
the crystal growth rate would show inhibition but would not be able to unambiguously 
pinpoint the mechanism by which this occurred. 
9.6.1 Inhibition through step pinning 
The classic description of pinning mechanisms is based on impurity adsorption at 
surfaces, steps or kinks[51-54]. In this case, impurities act as blockers at the sites where 
they adsorb, preventing the crystal step from propagating locally and thus causing a 
straight step to become scalloped. As steps curve, their velocity is reduced until they are 
eventually stopped when their radius of curvature reaches the critical radius (as defined in 
Section 9.5). In this model, the degree of inhibition depends on the supersaturation and 
the “blocker” concentration ([X]) on the surface (shown schematically in Figure 9.7b). 
Higher concentrations of adsorbate cause a greater reduction in velocity and this effects is 
more pronounced at lower supersaturations. Figure 9.8 illustrates a surface (calcite) 
where the normally straight steps are being pinned due to adsorbed peptides. At this 
particular supersaturation and impurity concentration, the steps continue to propagate but 
are slowed compared to a clean solution at the same supersaturation. A higher resolution 
image (Figure 8c) shows the tortuous path of the step edge, one of the classic signatures 
of step-pinning. 
 
9.6.2 Inhibition by reduction of step density 
The interaction of citrate with brushite presents a non-intuitive example of how modifiers 
can be used to tune growth rate. Brushite or apatitic phosphates are often found at the 
center of kidney stones. It has been suggested that brushite may aid the nucleation of 
calcium oxalate, the majority component of many stones, and could play a role in the 
aggregation of crystals to form a stone. Citrate is a common therapy administered to 
recurrent stone formers and is thought to inhibit crystal growth. In fact, constant 
composition experiments[40] have shown that citrate does inhibit the growth of 
brushite[55]. To investigate the mechanisms by which this occurs, AFM was used to 
directly image the atomic step kinetics and morphology.  
 
Because citrate forms complexes with calcium in solution, there are two ways of 
performing this experiment, as shown schematically in a supersaturation versus citrate 
concentration graph (Figure 9.9a). Citrate can either be added directly to a supersaturated 
calcium phosphate solution (Expt. 1) or citrate can be added while supplementing 
calcium to compensate for Ca-citrate complexes that form thus keeping the 
supersaturaton constant (Expt. 2).  While biological realism is always difficult to argue in 
in vitro experiments of this type, expt. 1 may seem a more natural experiment, (after all 
when you ingest citrate you don’t compensate calcium). However, from a crystal growth 
point of view the experiment designated by expt. 1 has two simultaneous affects: the 
change in supersaturation and the effects of citrate, which makes interpretation more 
difficult.  
 
The step velocity data obtained from AFM experiments bear this out. If one uses a 
titration method (expt. 1) without compensating for complexation, then as one might 
expect the step velocities decrease when citrate is added (Figure 9.9b, grey diamonds). 
However by adjusting the calcium to assure a constant supersaturation this effect is 
removed and the step velocities are constant up to 1mM citrate (Figure 9.9b, black 
circles). 
 
But in the case where supersaturation is held constant, if citrate does not reduce step 
velocities and yet does reduce the bulk growth rate, we are left with a puzzle. One 
possibility is that the step kinetics on facets other than the [010] face are modified. 
Another possibility presents itself from the AFM images (Figure 9.9); although step 
velocities and morphology remains unchanged, the step density decreases when citrate is 
added. Because facet growth rate is proportional to both the number and the speed of the 
steps, a lower density has a concomitant lower facet growth rate.  
 
In spiral growth, the distance between parallel steps (or step density) is a function of the 
time it takes for new step to begin to propagate As discussed in Section 9.5, this can 
either be related to the critical length or to the probability of nucleating a kink depending 
on whether thermodynamics or kinetics dominate. If the steps are in equilibrium, then the 
decrease in step density implies an increase in the critical length and a concomitant 
increase in step free energy. On the other hand, if the step motion is kinetically limited 
the effect of citrate is to decrease the probability of nucleating kinks, which are necessary 
for step motion.  In either case, the interaction with citrate has interesting implications for 
how organisms might use small amounts of additives to tune crystal growth rate. 
 
This example demonstrates two points. The first is well appreciated, but worth repeating, 
namely that additives that complex with other ions in the solution can be misidentified as 
inhibitors if changes in saturation state are not taken properly into account. Second, that 
bulk crystal growth rates depend not only on the velocity of atomic steps but also on the 
density of steps. In this example, AFM images showed that citrate molecules inhibit 
crystallization not by changing the speed of the atomic steps (as is generally assumed 
from bulk rate experiments) but rather by modifying the rate at which steps are generated. 
 
9.7 Outlook 
Over the past decade, a greater degree of quantification has been made possible through 
the use of scanning probe microscopy and advanced diffraction techniques. This coupled 
with a greater control of mineral interfaces through advances in synthesis and genetic 
engineering and the creation of templates with greater specificity and finer-scaled 
features, has led to our ability to measure and control biomineral growth to with 
unprecedented precision.  
 
While it is clear that the understanding and exploitation of self-assembling processes has 
made great advances, it is equally clear that this is an area of great depth that still has 
untapped potential. Most bio-inspired assembly processing occurs in aqueous 
environments, whereas most of the highest-resolution characterization tools are only 
viable in vacuum. Thus, new experimental tools enabling molecular-level 
characterization and the monitoring of dynamical processes in fluids would have a great 
impact on the field as a whole. Future advances will rely on yet faster and higher 
resolution imaging tools and there is a gaping need for sensitive spectroscopies capable 
of determining the bonding of surface species. Theoretical advance in crystal growth will 
need to embrace the complexity of multiple-component crystals and to examine the 
regime where the generation of kinks is rate-limiting. Overall advances will continue to 
rely on fundamental understanding of the physical controls on materials assembly from 
intermolecular force, to activation barriers, to thermodynamics. 
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Figure Captions: 
 
Figure 9. 1 Schematic graph of supersaturation normalized per growth unit (as defined in 
equation 9.2) versus the ratio of the activities of calcium and total inorganic phosphate. 
For σ<0, solutions are undersaturated and the mineral will dissolve, for σ=0, the solution 
is in equilibrium with a solid mineral phase and for σ>0, the solution is supersaturated 
with respect to the mineral phase. The slope of the line bounding the metastable region 
from unstable precipitation can have either a positive or negative slope depending on the 
kinetics associated with calcium versus phosphate incorporation. 
 
Figure 9.2 A solution map that plots the supersaturation (as defined in equation 9.2) 
versus a) the ratio of activities of Ca2+ and total inorganic phosphate (Pi) and b) the pH 
for various biological fluids.  For each fluid: serum (red), saliva (dark blue), plaque fluid 
(light blue), enamel (black), and urine (yellow), the supersaturation normalized per 
growth unit is shown with respect to HAP and DCPD in solid and dotted lines, 
respectively. The boundaries are approximate based on the range of fluid compositions 
cited in Table 9.3 and solubility products cited in Table 9.1. 
 
Figure 9.3 Plot of supersaturation (Equation 9.2) versus pH for a range of apatites from 
the least soluble FAP to the most soluble dentine.  The apatites are modeled with the 
stoichiometry of HAP but with solubility product as cited in Table 9.2. This is not strictly 
correct but a reasonable approximation for determining a range. 
 
Figure 9.4 Flow setup for in situ AFM experiments. The crystal is imaged while solution 
flow over the surface. 
 
Figure 9.5 (a,b) Two sequential images showing a growing hillock on the [010] facet of a 
DCPD crystal. Each image is 2µmx1.5µm and took 12 seconds to capture. Lines and a 
dot mark the same step in the two images. The step marked with a black line has a lower 
velocity than the other two steps and does not travel as far. The ratio of terrace widths is 
proportional to the ratio of step velocities. (c) Atomic model of step geometry with Ca in 
red, P in blue and O in yellow. The directions on the model are given for space group Ia. 
 
Figure 9.6 Three sequential images showing the growth of etch pits. Pits are labeled P1, 
P2, and P3. 
 
Figure 9.7 Schematic illustration of how different mechanisms of impurity interactions 
change the step velocity. As the impurity concentration ([X]) is increased the velocity 
versus supersaturation (a,b) or velocity versus orientation (c) change in characteristically 
different t ways. a) Strain caused by the substitution of impurity ions changes the 
equilibrium solubility (σ0), which is the concentration where the step velocity goes to 
zero. This causes the velocity curves to shift over but not change shape. b) Impurities that 
adsorb to steps can prevent the steps from moving due to the high local curvature of the 
step between the blocked points. This causes a “dead zone” where the velocity of the 
steps is slow compared to the clean solution (solid line) c) Surfactants change the step 
free energy. 2D slices of pseudo Wulff plots of calcite before and after the addition of 
aspartic acid, show that the step-edge free energy, γ(θ), changes due to adsorbed 
molecules at the steps. 
 
Figure 9.8 AFM images of the [104] face of calcite. The crystal is growing in solutions 
with and without peptide additions. Image (a) is in pure solutions whereas image (b) and 
(c) are in solution with 6µM of peptide. The steps become pinned (b) when the peptide is 
added, reducing the velocity of the growth steps. The image in (c) shows the detail of the 
torturous path of the step edge. 
 
Figure 9.9 Brushite-citrate experiments designed to study the influence of additives on 
crystal growth.  (a) Schematic showing the addition of a complexing agent (in this case 
citrate) when added to a growth solution (in this case with respect to brushite).  Expt. 1 
(dotted grey) demonstrates the case when the complexing of citrate with solution calcium 
is not accounted for resulting in a decrease in the supersaturation of brushite. Expt. 2 
(solid black) shows that a constant supersaturation can be maintained by compensating 
calcium to determine the affect of citrate independently. (b) Actual step velocity data 
showing a decrease in step velocity when the supersaturation is allowed to vary (grey) but 
constant when the supersaturation is held constant (black). d-e) AFM images of the same  
3µm x 1.5µm area on the [010] face of Brushite The crystal is growing in 37ºC solutions 
with σgu=0.14 before (d) and after (e) 2x10-6 M citrate citrate additions. The density of 
steps decreases when citrate is added, reducing the growth rate of this facet. 
Tables: 
Table 9.1 Calcium phosphate minerals and biominerals 
Calcium Phosphate Mineral Name Chemical Formula
 -Log Ksp 
(37ºC) Ca/P
a 
Dicalcium Phosphate  
(DCPA) Monetite CaHPO4 7.04 1 
Dicalcium Phosphate 
Dihydrate  
(DCPD) 
Brushite CaHPO4•2H2O 6.63 1 
β-Tricalcium Phosphate  
(TCP) Whitlockite Ca3(PO4)2 29.55 1.5 
Octacalcium Phosphate  
(OCP)  Ca8H2(PO4)6•5H2O 97.4 1.33 
Hydroxyapatite  
(HAP) Apatite Ca10(OH)2(PO4)6 117.3 1.67 
Fluoroapaptite  
(FAP)  Ca10F2(PO4)6 115.8 – 120.2 1.67 
Carbonated Apatite  
(CAP)  Ca10(OH)2(PO4,CO3)6 111.5 – 115.6  
Human Bone[9]  (Ca,Z)10(PO4,Y)6(OH,X)2b  1.7 
Human Enamel[11]   (Ca,Z)9.4(PO4,Y)5.98(OH,X)1.3b,c 96.1 – 117.5 1.65 
Human Dentine[11]   (Ca,Z)8.96(PO4,Y)5.96(OH,X)0.78b,d 88.8 - 104.0 1.61 
a Molar ratio 
b Z=Na, Mg, K, Sr, etc; Y=CO3, HPO4; X=Cl, F  
c (Ca)9.12(Mg)0.06(Na)0.22(HPO4)0.20(CO3)0.46(PO4)5.32(OH,F)1.3 
d (Ca)8.44(Mg)0.28(Na)0.24(HPO4)0.26(CO3)0.72(PO4)4.98(OH,F)0.78 
 
Table 9.2 Pathological and Normal Calcium Phosphate Minerals found in the body 
Tissue Mineral Disease Model solution Reference 
Loops of henle Apatite, DCPD Kidney stone formation Urine [15] 
Teeth HAP, DCPD, TCP, OCP Calculus/Caries Plaque/Saliva [16, 17] 
Salivary glands DCPD Sialolith  Saliva [18] 
Joint DCPD, HAP Rheumatoid & osteoarthritis 
Synovial (joint) 
fluid [19] 
 
 
Table 9.3 Composition ranges (in mM) of human fluids and associated mineral 
saturation states of phosphates. 
 Serum Saliva[21, 22] Enamel Fluid[23] 
Plaque 
Fluid[24] Urine[25] 
Na+ 130 - 150 10 140 6.8 - 50 50 - 250 
Cl- 99 - 110 23 150 14 - 52 64 - 380 
Ca2+ 2.1 - 2.9 0.40 - 2.1 0.5 0.8 - 8.6 0.81 - 7.8 
Pi 0.74 - 1.5 2.9 - 11 3.9 7.8 - 29 7.2 - 45 
HCO3- 8.2 - 9.3 2.1 - 25 10   
K+ 3.6 - 5.6 23 21 38 - 90 20 - 96 
Mg2+ 0.74 - 1.5 0.21 0.8 1.3 - 5.5 0.70 - 7.8 
F- 0.01 - 0.02 0.005 0.005 0.0013 - 0.018  
SO42- 0.08 - 0.12    0.50 - 50 
NH4+  4  19 - 64 10 - 56 
      
Growth Parameters 
pH 7.4 5.5 - 7.5 7.2 - 7.3 5.69 - 7.08 4.8 - 8.0 
{Ca}/{Pi} 1.31 - 2.54 0.02 - 0.69 0.145a 0.01 - 1.40 0.05 - 1.89 
I (mM) 152 - 153 39 - 46 165 a 152 - 155 258 - 274 
σgu DCPD -0.9 - -0.5 -1.6 - 1.0 -0.50 a -1.1 - 1.7 -2.1 - 1.6 
σgu TCP 0.8 - 1.2 -1.6 - 2.6 0.81 a -1.2 - 3.0 -2.7 - 3.5 
σgu OCP 0.4 - 0.8 -1.3 - 2.0 0.49 a -0.9 - 2.4 -2.1 - 2.7 
σgu HAP 2.3 - 2.7 -0.2 - 3.8 2.22 a  0.2 - 4.2 -1.3 - 4.8 
a Average values 
 
Table 9.4 Crystal growth controls and their effect on the bulk solution and the 
crystal surface. 
Parameter 
(symbol) 
Effect on Bulk Solution Effect on Surface 
Supersaturation 
(S) 
Stability of solid phases Net flux to surface; Determines 
mode of growth (island 
nucleation versus incorporation 
at existing steps). 
pH  Solution speciation (and 
subsequently supersaturation) 
Net charge of surface due to 
degree of protonation 
Ionic Strength (I) Screening length within the 
solution – activity 
coefficients 
Debye Length of the double 
layer 
Temperature (T)  Solution speciation through 
temperature dependence of 
association constants 
Kinetics of adsorption, 
desorption, diffusion 
Ratio of calcium 
to phosphate ions 
{Ca2+}/{Pi} 
Solution speciation Kinetics of incorporation – in 
principle, activation barriers 
differ for calcium and phosphate 
ions  
Additive 
concentration 
([X]) 
Can change solution 
speciation (and subsequently 
supersaturation) 
Various: Step-pinning, 
Surfactant, Blocking layer, 
Incorporation, etc. 
 
 
Table 9.5: Examples of biological regulation that change the mineralizing fluid. 
Cell Activity Biological regulation Potential Effect on 
Mineralization 
Base fluid 
Bone growth Osteoblasts produce 
enzyme Akaline 
Phosphatase 
Increase Pi Matrix Vesicle 
Bone growth Osteoblasts produce 
enzyme Akaline 
Phosphatase 
Reduce inhibitor 
concentration 
Matrix Vesicle 
Bone resorption Osteoclasts activate 
H+-ATPase pump 
Decrease pH Resorption 
Lacuna/serum 
Tooth 
dissolution 
(caries) 
Bacteria produce 
lactic acid 
Decrease pH Saliva or plaque 
 
 









